» Articles » PMID: 31676912

The Global Burden of Urinary Bladder Cancer: an Update

Overview
Journal World J Urol
Specialty Urology
Date 2019 Nov 3
PMID 31676912
Citations 405
Authors
Affiliations
Soon will be listed here.
Abstract

Bladder cancer is among the top ten most common cancer types in the world, with approximately 550,000 new cases annually. The highest burden of bladder cancer is currently falling on most developed communities across the globe. But with an anticipated shift in world demographics with growing and aging populations mainly on the African continent, and important shifts in exposure to different risk factors across the world, this is likely to change over the next decades. In this review, we provide an overview of the current incidence, mortality, prevalence, survival, risk factors and costs of bladder cancer worldwide.

Citing Articles

Comparison of Remimazolam-Based Monitored Anesthesia Care and Inhalation-Based General Anesthesia in Transurethral Resection of Bladder Tumor: A Randomized-Controlled Trial.

Cho J, Ham W, Lee B, Kim H, Park J Cancers (Basel). 2025; 17(5).

PMID: 40075695 PMC: 11898644. DOI: 10.3390/cancers17050848.


Clinical outcomes of avelumab and pembrolizumab in advanced urothelial cancer: an observational multicenter retro-prospective study on patients undergoing treatment in clinical practice (AVePEm study).

Zacchi F, Sordo A, Torresan I, Lorenzi C, Tasselli E, Pafumi S Front Oncol. 2025; 15:1532421.

PMID: 40061901 PMC: 11885129. DOI: 10.3389/fonc.2025.1532421.


Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: an observational study from the global burden of disease study 2021.

Su X, Tao Y, Chen F, Han X, Xue L Sci Rep. 2025; 15(1):7655.

PMID: 40038504 PMC: 11880295. DOI: 10.1038/s41598-025-92033-5.


BIN1 inhibited tumor growth, metastasis and stemness by ALDH1/NOTCH pathway in bladder carcinoma.

Chen S, Zhang Y, Li X, Wang J, Li K, Wan S Hereditas. 2025; 162(1):29.

PMID: 40016843 PMC: 11866615. DOI: 10.1186/s41065-025-00384-w.


Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherapy: a meta-analysis.

Liang W, Wang Z, Huang Z, Huang Y, Li C, Liang Y Front Immunol. 2025; 16:1430673.

PMID: 40013152 PMC: 11860080. DOI: 10.3389/fimmu.2025.1430673.


References
1.
Richters A, Dickman P, Witjes J, Boormans J, Kiemeney L, Aben K . Bladder cancer survival: Women only fare worse in the first two years after diagnosis. Urol Oncol. 2019; 37(12):853-861. DOI: 10.1016/j.urolonc.2019.08.001. View

2.
Baiardini I, Sorino C, Di Marco F, Facchini F . Smoking cessation, anxiety, mood and quality of life: reassuring evidences. Minerva Med. 2014; 105(5 Suppl 1):15-21. View